511509 — Vivo Bio Tech Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual income statement for Vivo Bio Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	554	518	514	522	455
Cost of Revenue
Gross Profit	468	446	400	455	416
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	481	397	430	400	337
Operating Profit	73	121	83.7	122	118
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	42.5	86.2	44.7	46.2	40.6
Provision for Income Taxes
Net Income After Taxes	44.4	56.8	22	26.5	25.3
Net Income Before Extraordinary Items
Net Income	44.4	56.8	22	26.5	25.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	44.4	56.8	22	26.5	25.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.45	4.23	1.55	1.79	1.51